[go: up one dir, main page]

AU4198200A - Anti-apoptotic fusion polypeptide - Google Patents

Anti-apoptotic fusion polypeptide

Info

Publication number
AU4198200A
AU4198200A AU41982/00A AU4198200A AU4198200A AU 4198200 A AU4198200 A AU 4198200A AU 41982/00 A AU41982/00 A AU 41982/00A AU 4198200 A AU4198200 A AU 4198200A AU 4198200 A AU4198200 A AU 4198200A
Authority
AU
Australia
Prior art keywords
fusion polypeptide
apoptotic
apoptotic fusion
polypeptide
fusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41982/00A
Other languages
English (en)
Inventor
Alicia Algeciras-Schminich
Carlos Paya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mayo Clinic in Florida
Original Assignee
Mayo Foundation for Medical Education and Research
Mayo Clinic in Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayo Foundation for Medical Education and Research, Mayo Clinic in Florida filed Critical Mayo Foundation for Medical Education and Research
Publication of AU4198200A publication Critical patent/AU4198200A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Peptides Or Proteins (AREA)
AU41982/00A 1999-04-05 2000-04-05 Anti-apoptotic fusion polypeptide Abandoned AU4198200A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12786799P 1999-04-05 1999-04-05
US60127867 1999-04-05
US12802199P 1999-04-06 1999-04-06
US60128021 1999-04-06
PCT/US2000/009002 WO2000059935A1 (fr) 1999-04-05 2000-04-05 Polypeptide hybride anti-apoptose

Publications (1)

Publication Number Publication Date
AU4198200A true AU4198200A (en) 2000-10-23

Family

ID=26826046

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41982/00A Abandoned AU4198200A (en) 1999-04-05 2000-04-05 Anti-apoptotic fusion polypeptide

Country Status (2)

Country Link
AU (1) AU4198200A (fr)
WO (1) WO2000059935A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005090392A1 (fr) * 2004-03-16 2005-09-29 Inist Inc. Compositions tolerogenes a base de tat et methodes de production et d'utilisation associees
US20110224133A1 (en) * 2008-07-25 2011-09-15 University Of Southern California Highly Potent Peptides To Control Cancer And Neurodegenerative Diseases
CA2755897C (fr) 2009-03-23 2020-01-28 Nanirx, Inc. Traitement du cancer avec des polypeptides immunostimulants derives de tat de vih
EP3052127A1 (fr) 2013-10-04 2016-08-10 PIN Pharma, Inc. Polypeptides immunostimulants dérivés du tat de vih utilisés dans le traitement du cancer
CN110483647B (zh) * 2019-08-19 2021-02-09 重庆大学附属肿瘤医院 一种抗肿瘤多肽及其应用

Also Published As

Publication number Publication date
WO2000059935A1 (fr) 2000-10-12
WO2000059935A9 (fr) 2002-01-03

Similar Documents

Publication Publication Date Title
AU3562299A (en) Inhibin-hbc fusion protein
AU7382000A (en) Composite joint configuration
AU6058500A (en) Fusion protein and uses thereof
AU1951201A (en) Peptide antigens
AU2001291049A1 (en) Defensin-antigen fusion proteins
AU6045900A (en) Interaction-activated proteins
AU5553600A (en) Fusion proteins incorporating lysozyme
AU2001284418A1 (en) Novel polypeptide
GB9923177D0 (en) Novel polypeptide
GB9913437D0 (en) Fusion proteins
AU6223700A (en) Gtp-binding associated proteins
AU9798398A (en) Gfp-annexin fusion proteins
AU5706000A (en) Useful polypeptide
AU4930399A (en) Novel Polypeptide
AU4198200A (en) Anti-apoptotic fusion polypeptide
AU2691500A (en) Novel polypeptide
GB9923889D0 (en) Novel polypeptide
AU4778600A (en) Novel polypeptide
AU5911000A (en) Sgip peptides
AU6983000A (en) Chimeric proteins
AU2109200A (en) Polypeptide
AU1184800A (en) Novel polypeptide
AU1552800A (en) Coupled peptides
AU1228201A (en) Umlr polypeptides
AU6712600A (en) Polypeptides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase